We are live on ! Find out more
NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $121M
1-Year Est. Return 56.89%
This Fund
S&P 500
This Quarter Est. Return
-10.87%
1 Year Est. Return
+56.89%
3 Year Est. Return
+244.35%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$322M
AUM Growth
–
Cap. Flow
+$333M
Cap. Flow %
103.52%
Top 10 Hldgs %
93.06%
Holding
24
New
24
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
EAR
Eargo, Inc. Common Stock
EAR
+$121M
2
NFH
New Frontier Health Corporation Ordinary Shares
NFH
+$93.6M
3
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$27.4M
4
BOLT icon
Bolt Biotherapeutics
BOLT
+$23.7M
5
HRMY icon
Harmony Biosciences
HRMY
+$23.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 68.19%
2 Financials 28.98%
3 Communication Services 0.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EAR
1
DELISTED
Eargo, Inc. Common Stock
EAR
$115M 35.8%
+144,336
New +$121M
NFH
2
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
$93.3M 28.98%
+8,350,000
New +$93.6M
KRTX
3
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$26.8M 8.32%
+234,811
New +$27.4M
HRMY icon
4
Harmony Biosciences
HRMY
$2.08B
$21.7M 6.74%
+768,708
New +$23.1M
BOLT icon
5
Bolt Biotherapeutics
BOLT
$7.4M
$18M 5.61%
+58,348
New +$23.7M
BEAM icon
6
Beam Therapeutics
BEAM
$2.68B
$6.26M 1.95%
+48,660
New +$3.88M
GRTX
7
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$6.03M 1.87%
+613,223
New +$4.98M
NVTA
8
DELISTED
Invitae Corporation
NVTA
$4.88M 1.52%
+144,667
New +$4.7M
XENE icon
9
Xenon Pharmaceuticals
XENE
$6.1B
$3.69M 1.15%
+197,880
New +$3.65M
NFH.WS
10
DELISTED
New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a
NFH.WS
$3.67M 1.14%
+1,580,000
New +$4.5M
VIR icon
11
Vir Biotechnology
VIR
$1.46B
$3.25M 1.01%
+68,663
New +$3.12M
SRRA
12
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$2.55M 0.79%
+130,979
New +$2.38M
ARDX icon
13
Ardelyx
ARDX
$1.24B
$2.46M 0.77%
+325,233
New +$2.4M
EXAS
14
DELISTED
Exact Sciences
EXAS
$2.17M 0.67%
+17,464
New +$2.08M
ALXO icon
15
ALX Oncology
ALXO
$262M
$1.91M 0.59%
+34,950
New +$2.09M
OTIC
16
DELISTED
Otonomy, Inc.
OTIC
$1.9M 0.59%
+851,000
New +$1.97M
KALV
17
DELISTED
KalVista Pharmaceuticals
KALV
$1.89M 0.59%
+78,720
New +$2.06M
DBVT
18
DBV Technologies
DBVT
$813M
$1.56M 0.48%
+28,550
New +$1.71M
RUBY
19
DELISTED
Rubius Therapeutics, Inc
RUBY
$1.39M 0.43%
+56,768
New +$1.42M
EXEL icon
20
Exelixis
EXEL
$13.9B
$1.17M 0.36%
+64,200
New +$1.5M
RETA
21
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1.17M 0.36%
+8,265
New +$933K
FLNT
22
Fluent
FLNT
$106M
$571K 0.18%
+32,467
New +$641K
SYBX
23
DELISTED
Synlogic
SYBX
$267K 0.08%
+4,576
New +$250K
AKRO
24
DELISTED
Akero Therapeutics
AKRO
$86K 0.03%
+3,470
New +$97.5K

Similar funds

TCM
TT Capital Management Coto De Caza, California $121M AUM 1.94% 1-Year Est. Return
MAM
Mirabaud Asset Management London, United Kingdom $121M AUM 20.69% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
CCM
Candelo Capital Management New York $121M AUM 113.39% 1-Year Est. Return
CCM
CFO Capital Management Fairfield, Connecticut $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Nan Fung Group Holdings's Q2 2021 Portfolio in Review

Q2 2021 is the first quarter with a 13F filing on record for Nan Fung Group Holdings, which disclosed 24 positions worth $322M. Its ten largest holdings account for 93% of the portfolio.

Its largest position is Eargo, Inc. Common Stock: 144,336 shares worth $115M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, followed by Financials and Communication Services.

  • Nan Fung Group Holdings's largest Q2 2021 buy was Eargo, Inc. Common Stock: 144,336 shares worth $115M.
  • Nan Fung Group Holdings's ten largest holdings make up 93% of its $322M portfolio in Q2 2021.
  • Nan Fung Group Holdings disclosed 24 positions in Q2 2021, its first 13F filing on record.

Based on Nan Fung Group Holdings's 13F filing for Q2 2021, filed 22 Sep 2021.